Research

Immunopeptides

Cells display short peptides on their surface through human leukocyte antigen (major histocompatibility complex) molecules, and T cells use them to tell healthy cells from infected or cancerous ones. A growing share of these immunopeptides comes from non-canonical sources, including small open reading frames.

Approaches

  • Immunopeptidomics by mass spectrometry: isolating peptides bound to human leukocyte antigen molecules and identifying them at scale.
  • Integrated search strategies that combine proteogenomic databases with mass spectrometry to find non-canonical class I and class II peptides.
  • Translational studies that evaluate newly found peptides as candidate targets for tumor immunotherapy.
Illustration of molecules on and around the cell surface

Selected publications

* corresponding author; # equal contribution. Lab head in bold.

All publications →